0.41 USD
▲+0.01+12.79%
盘后 0.38 +4.30%
2026-08-03
市值
$20.15M
市盈率
—
EPS
-0.75
股息率
—
52 周区间
0.27 – 2.38
成交量
605.04K
Beta
0.23
目标价
—
52W 低 0.2752W 高 2.38
价格走势
公司简介
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatm...